Anzeige
❌
Mehr »
Mittwoch, 18.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrNovo amps up Wegovy marketing with DJ Khaled spinning his weight-loss tale
DoPharmas should stay agile as Democrats amp up scrutiny over Trump's MFN deals
DoFDA appears to pause controversial speedy review program, complete response letter disclosures
DoOrzeyful's 'lighter' DEA schedule paves way for Takeda's first-in-class narcolepsy launch
DoRadiopharma player PharmaLogic snaps up Lantheus' CDMO business, plant as Curium acquisition advances
DoAI models from Google, Anthropic and more lean on recommending promoted drugs: study
11.11.FDA cites record request breakdowns in trio of warning letters to API makers
11.11.Legend Biotech shares fall 16% after first earnings report under new CEO
11.11.BioNTech pays $205M for FDA voucher to speed up 'late-stage oncology pipeline'
11.11.Aurobindo unit Eugia recalls antibiotic lot, citing glass particle concerns
10.11.ImmunityBio juggles phase 3 win and 20% stock crash en route to Anktiva front-line expansion
10.11.Summit sheds commercial leaders ahead of ivonescimab's FDA decision
10.11.J&J readies Caplyta for FDA label expansion after 2nd phase 3 win in bipolar mania
10.11.After court win, WuXi AppTec scores removal from US list of Chinese military companies
10.11.FDA orders new eye risk be listed on a dozen GLP-1s, including Novo's Ozempic, Lilly's Zepbound
10.11.Phillips Medisize strikes deal to expand UK inhalation production
10.11.Vertex lays off 78 Crinetics staffers amid $10B integration
10.11.Insulet, Marvel Comics smash diabetes stigma with new Omnipod-powered superhero
10.11.Bayer brings factor XIa to US stroke prevention with FDA nod for 1st-in-class asundexian
09.11.Veradermics wraps phase 3 program in men with 'better-than-expected' hair growth at 1 year
09.11.FDA opens safety probe into Novartis' Zolgensma over potential tumor risks
09.11.J&J's Icotyde pill drives biologic-like efficacy in psoriatic arthritis despite high-dose miss
09.11.Lilly looks to gird Foundayo label after late-stage win in sleep apnea
09.11.Moderna moves UK commercial digs to heart of London's 'knowledge quarter'
09.11.Agentic AI Is Rewriting The Pharma Marketing Playbook